Suppr超能文献

左甲状腺素替代疗法对原发性甲状腺功能减退症患者颈动脉内膜中层厚度的影响。

Effects of L-thyroxine replacement therapy on carotid intima-media thickness in patients with primary hypothyroidism.

作者信息

Cakal E, Turgut A T, Demirbas B, Ozkaya M, Cakal B, Serter R, Aral Y

机构信息

Department of Endocrinology and Metabolism, Ankara Training and Research Hospital, Ankara, Turkey.

出版信息

Exp Clin Endocrinol Diabetes. 2009 Jun;117(6):294-300. doi: 10.1055/s-0028-1085998. Epub 2008 Sep 30.

Abstract

BACKGROUND

In hypothyroid patients, the risk for cardiovascular disease is higher and ultrasonography (US) demonstrates that the carotid intima-media thickness (CIMT) is significantly increased. We hypothesized that L-thyroxine replacement therapy might be able to reverse the process associated with increase in CIMT in patients with primary hypothyroidism.

PATIENTS

In this study, a total of 43 females with primary hypothyroidism and 21 euthyroid females as control group were included. In hypothyroid patients, CIMT was measured using US and the measurement was repeated 6 months after euthyroidism was achieved with L-thyroxine replacement therapy. Biochemically, lipid profile, high sensitivity C-reactive protein (hs-CRP), plasminogen activator inhibitory-1 (PAI-1) and fibrinogen levels were measured.

RESULTS

It was found that in hypothyroid patients the value of CIMT was significantly higher than those in control group (0.534+/-0.08 mm vs. 0.443+/-0.05 mm, respectively; p<0.001). However, the value of CIMT decreased significantly in all but two patients after euthyroidism was achieved with L-thyroxine replacement therapy (0.534+/-0.08 mm and 0.465+/-0.06 mm, respectively; p<0.001). Moreover, there was a positive correlation between the CIMT value and all other parameters except patient age, including total cholesterol (r=0.437, p=0.003), low density lipoprotein (LDL) cholesterol (r=0.415, p=0.006), total cholesterol/high density lipoprotein (HDL) cholesterol ratio (r=0.391, p=0.01) basal levels.

CONCLUSION

This report demonstrates that in patients with primary hypothyroidism, in addition to values of total cholesterol, LDL cholesterol, and total cholesterol/HDL cholesterol ratio, the CIMT value was higher compared to healthy controls. Importantly, the value of CIMT, as well as the levels of lipid parameters, decreased to normal level after L-thyroxine replacement therapy. Furthermore, significant correlations were detected between the changes of CIMT and the changes of total cholesterol and LDL cholesterol respectively. Thus, it is suggested that an increased CIMT value may be an objective sign of accelerated atherosclerosis in patients with primary hypothroidism.

摘要

背景

甲状腺功能减退患者患心血管疾病的风险更高,超声检查(US)显示颈动脉内膜中层厚度(CIMT)显著增加。我们推测左甲状腺素替代疗法可能能够逆转原发性甲状腺功能减退患者CIMT增加相关的进程。

患者

本研究纳入了43例原发性甲状腺功能减退女性患者和21例甲状腺功能正常女性作为对照组。对甲状腺功能减退患者,使用超声测量CIMT,并在左甲状腺素替代疗法使甲状腺功能恢复正常6个月后重复测量。生化方面,测量血脂、高敏C反应蛋白(hs-CRP)、纤溶酶原激活物抑制因子-1(PAI-1)和纤维蛋白原水平。

结果

发现甲状腺功能减退患者的CIMT值显著高于对照组(分别为0.534±0.08mm和0.443±0.05mm;p<0.001)。然而,在左甲状腺素替代疗法使甲状腺功能恢复正常后,除两名患者外,所有患者的CIMT值均显著下降(分别为0.534±0.08mm和0.465±0.06mm;p<0.001)。此外,CIMT值与除患者年龄外的所有其他参数呈正相关,包括总胆固醇(r=0.437,p=0.003)、低密度脂蛋白(LDL)胆固醇(r=0.415,p=0.006)、总胆固醇/高密度脂蛋白(HDL)胆固醇比值(r=0.391,p=0.01)基础水平。

结论

本报告表明,在原发性甲状腺功能减退患者中,除总胆固醇、LDL胆固醇和总胆固醇/HDL胆固醇比值外,CIMT值也高于健康对照组。重要的是,左甲状腺素替代疗法后,CIMT值以及血脂参数水平降至正常水平。此外,分别检测到CIMT变化与总胆固醇和LDL胆固醇变化之间存在显著相关性。因此,提示CIMT值升高可能是原发性甲状腺功能减退患者动脉粥样硬化加速的一个客观标志。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验